Answers are grounded in this paper and cite their sources.
Detection of creatinine, a primary biomarker for assessing kidney function, is essential for diagnosing and managing renal conditions. Conventional methods for creatinine measurement, such as serum assays, commercial kits, and clearance tests, often require laborious equipment and extensive processing times, which may not be feasible for a point-of-care (POC) setting. Recent advances in nanotechnology have led to the development of novel electrochemical and colorimetric nano(bio)sensors that offer promising solutions for rapid, reliable, selective, handheld, and on-site detection of creatinine. This review provides a forward-looking overview of cutting-edge sensing technologies, focusing on creatinine biosynthesis, nano(bio)sensor principles, and advanced applications in POC diagnostics of renal biomarkers. A comparative analysis of electrochemical and colorimetric nano(bio)sensors for creatinine detection is also highlighted. • Recent advances in electrochemical and colorimetric nano(bio)sensors for creatinine. • Advantages and limitations of both sensors in creatinine clinical detection. • Nanomaterials boost analytical performance in point-of-care creatinine sensing. • Prospects of electrochemical and colorimetric nano(bio)sensors are highlighted.
No takes yet. Share an insight, caveat, or question.
Murti et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: